Shares of Opiant Pharmaceuticals Inc. (OPNT) have lost nearly 25% of their value so far this year and trade around $25.
Opiant Pharma is a commercial-stage specialty pharmaceutical company developing medicines to treat addictions and drug overdose. The lead product is NARCAN nasal spray, which is approved for opioid overdose in the U.S. and Canada.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.